Literature DB >> 31124898

Obesity as protective against, rather than a risk factor for, postoperative Clostridium difficile infection: A nationwide retrospective analysis of 1,426,807 surgical patients.

Karien Meier1, Ask T Nordestgaard, Ahmed I Eid, Napaporn Kongkaewpaisan, Jae Moo Lee, Manansun Kongwibulwut, Kelsey R Han, Nikolaos Kokoroskos, April E Mendoza, Noelle Saillant, David R King, George C Velmahos, Haytham M A Kaafarani.   

Abstract

BACKGROUND: Recent studies suggest that obesity is a risk factor for Clostridium difficile infection, possibly due to disruptions in the intestinal microbiome composition. We hypothesized that body mass index (BMI) is associated with increased incidence of C. difficile infection in surgical patients.
METHODS: In this nationwide retrospective cohort study in 680 American College of Surgeons National Surgical Quality Improvement Program participating sites across the United States, the occurrence of C. difficile infection within 30 days postoperatively between different BMI groups was compared. All American College of Surgeons National Surgical Quality Improvement Program patients between 2015 and 2016 were classified as underweight, normal-weight, overweight, or obese class I-III if their BMI was less than 18.5, 18.5 to 25, 25 to 30, 30 to 35, 35 to 40 or greater than 40, respectively.
RESULTS: A total of 1,426,807 patients were included; median age was 58 years, 43.4% were male, and 82.9% were white. The postoperative incidence of C. difficile infection was 0.42% overall: 1.11%, 0.56%, 0.39%, 0.35%, 0.33% and 0.36% from the lowest to the highest BMI group, respectively (p < 0.001 for trend). In univariate then multivariable logistic regression analyses, adjusting for patient demographics (e.g., age, sex), comorbidities (e.g., diabetes, systemic sepsis, immunosuppression), preoperative laboratory values (e.g., albumin, white blood cell count), procedure complexity (work relative unit as a proxy) and procedure characteristics (e.g., emergency, type of surgery [general, vascular, other]), compared with patients with normal BMI, high BMI was inversely and incrementally correlated with the postoperative occurrence of C. difficile infection. The underweight were at increased risk (odds ratio, 1.15 [1.00-1.32]) while the class III obese were at the lowest risk (odds ratio, 0.73 [0.65-0.81]).
CONCLUSION: In this nationwide retrospective cohort study, obesity is independently and in a stepwise fashion associated with a decreased risk of postoperative C. difficile infection. Further studies are warranted to explore the potential and unexpected association. LEVEL OF EVIDENCE: Prognostic/Epidemiologic, Level IV.

Entities:  

Mesh:

Year:  2019        PMID: 31124898     DOI: 10.1097/TA.0000000000002249

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  7 in total

1.  Morbid Obesity Increases 30-Day Readmission and Morbidity in Clostridiodes difficile Infection.

Authors:  Russell D Dolan; Marwan S Abougergi; Allison R Schulman
Journal:  Obes Surg       Date:  2021-02-05       Impact factor: 4.129

2.  The Effect of Immunosuppression on Emergency Colectomy Outcomes: A Nationwide Retrospective Analysis.

Authors:  Majed W El Hechi; Jae Moo Lee; Leon Naar; Mohamad El Moheb; Nikolaos Kokoroskos; George C Velmahos; Noelle N Saillant; Haytham M A Kaafarani; April E Mendoza
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

3.  Body mass index and risk of clostridioides difficile infection: a systematic review and meta-analysis.

Authors:  Nipith Charoenngam; Ben Ponvilawan; Jerapas Thongpiya; Pitchaporn Yingchoncharoen; Thanat Chaikijurajai; Natapat Chaisidhivej; Caroline M Apovian; Patompong Ungprasert
Journal:  Infection       Date:  2022-01-05       Impact factor: 3.553

4.  Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation.

Authors:  Ghadeer K Dawwas; Colleen M Brensinger; Ravy K Vajravelu; Qufei Wu; Colleen R Kelly; Loren Laine; Gary D Wu; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-08       Impact factor: 11.382

5.  Immunosuppression and Clostridioides (Clostridium) difficile Infection Risk in Metabolic and Bariatric Surgery Patients.

Authors:  Elisa Morales-Marroquin; Luyu Xie; Madhuri Uppuluri; Jaime P Almandoz; Nestor de la Cruz-Muñoz; Sarah E Messiah
Journal:  J Am Coll Surg       Date:  2021-05-17       Impact factor: 6.532

6.  Obesity is not associated with adverse outcomes among hospitalized patients with Clostridioides difficile infection.

Authors:  Alyyah Malick; Ying Wang; Jordan Axelrad; Hojjat Salmasian; Daniel Freedberg
Journal:  Gut Pathog       Date:  2022-01-29       Impact factor: 4.181

7.  Microbiological, Clinical and Radiological Aspects of Diabetic Foot Ulcers Infected with Methicillin-Resistant and -Sensitive Staphylococcus aureus.

Authors:  Maria Stańkowska; Katarzyna Garbacz; Anna Korzon-Burakowska; Marek Bronk; Monika Skotarczak; Anna Szymańska-Dubowik
Journal:  Pathogens       Date:  2022-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.